APAleksandr A. Postnov

Aleksandr A. Postnov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandr A. Postnov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anti-N-METHYL-D-aspartate receptor encephalitis, recurrent course

    by E. I. Shermatyuk, D. I. Skulyabin, N. V. Tsygan, S. Yu. Golokhvastov, A. D. Postnov, M. G. Chernenok, V. A. Medvedev, E. S. Kurasov, I. V. Litvinenko

    Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR-encephalitis) was first described as an immune-mediated disorder of behavior and cognitive functions in patients with ovarian teratoma. Subsequently, it was recognized as a separate type of autoimmune encephalitis with a characteristic clinical picture and the possibility of development in the absence of data on tumor formations. The course can have both monophase and recurrent variants with periods of improvement or stabilization of the condition and subsequent progression of the disease. The article presents a clinical observation of a patient with a relapse of the disease 2 years later. The diagnosis of anti-NMDAR-encephalitis was established based on the presence of antibodies to NMDA receptor epitopes in the patient's cerebrospinal fluid, both at the onset of the disease and during the relapse. According to foreign literature, the incidence of recurrent anti-NMDAR-encephalitis varies from 12% to 24%, depending on the study, which requires additional monitoring of patients with this diagnosis.

  • Open Access

    Risk factors and differential prevention of in-hospital hemorrhagic stroke

    by Evgeniy I. Shermatyuk, Nikolay V. Tsygan, Aleksandr A. Postnov, Maxim G. Chernenok, Vadim A. Medvedev, Tatyana V. Sergeeva, Igor V. Litvinenko, Цыган Николай Васильевич

    In-hospital hemorrhagic stroke is a subtype of acute cerebrovascular disease of hemorrhagic origin that includes all forms of non-traumatic intracranial hemorrhage (including subarachnoid hemorrhage) occurring in patients hospitalized for diagnostic evaluation or treatment of another condition, or admitted for a diagnostic or therapeutic procedure. Unlike in-hospital ischemic stroke, the epidemiology of in-hospital hemorrhagic stroke remains insufficiently studied. In-hospital hemorrhagic stroke is a relatively rare competing condition, yet is characterized by a high rate of adverse outcomes (mortality may reach 50%), which may significantly contribute to in-hospital mortality and, similar to in-hospital ischemic stroke, is highly relevant and requires active investigation. In addition to common and specific risk factors, unique risk factors directly related to diagnostic and therapeutic procedures performed in the hospital setting play an important role in the pathogenesis of in-hospital hemorrhagic stroke. This article discusses the most frequent medical procedures associated with the highest risk of in-hospital hemorrhagic stroke, including endovascular surgical interventions, systemic thrombolytic therapy, and antithrombotic therapy. Based on the analysis of risk factors, currently relevant options for differentiated prevention are presented. Recognition of in-hospital hemorrhagic stroke as a distinct clinical condition will enable more effective targeted prevention, reduce in-hospital mortality, and improve clinical outcomes of in-hospital hemorrhagic stroke.